(Q43579501)

English

Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

Bexarotene capsules and gel for previously treated patients with cutaneous T-cell lymphoma: results of the Australian patients treated on phase II trials (English)

1 reference

Europe PubMed Central

24 November 2017

phase II clinical trial

0 references

author name string

Prince HM

1

1 reference

Europe PubMed Central

24 November 2017

McCormack C

2

1 reference

Europe PubMed Central

24 November 2017

Ryan G

3

1 reference

Europe PubMed Central

24 November 2017

Baker C

4

1 reference

Europe PubMed Central

24 November 2017

Rotstein H

5

1 reference

Europe PubMed Central

24 November 2017

Davison J

6

1 reference

Europe PubMed Central

24 November 2017

Yocum R

7

1 reference

Europe PubMed Central

24 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2001

1 reference

Europe PubMed Central

24 November 2017

Australasian Journal of Dermatology

1 reference

Europe PubMed Central

24 November 2017

42

1 reference

Europe PubMed Central

24 November 2017

2

1 reference

Europe PubMed Central

24 November 2017

91-97

1 reference

Europe PubMed Central

24 November 2017

Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

The effect of isotretinoin in six patients with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

A novel approach for the evaluation and treatment of psoriasis. Oral or topical use of 1,25-dihydroxyvitamin D3 can be a safe and effective therapy for psoriasis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

Deafness from eighth cranial nerve involvement in a patient with large-cell transformation of mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-0960.2001.00488.X

21 January 2018

Identifiers

10.1046/J.1440-0960.2001.00488.X

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43579501&oldid=2101620376"